Where do you find a clear signal in a world of static?

In a time of rapid change cut through the noise,

the economist goes beyond the headlines to decode the forces shaping today

and defining tomorrow.

Get the full story.

It's more than news.

It's a trusted global perspective.

The economist know which way is up.

The views expressed on this podcast are those of the participants, not of Roiders'

news. This week, we are discussing Chinese audit changes, vaccine wars, and UK tax cuts.

Welcome back to the Views Room, the podcast from Reuters breaking views where columnists from around the world talk about the big stories of the week.

I'm your host, Amy Donlan, coming to you from London.

China is opening its doors to greater scrutiny.

In a new pact signed this week, Washington will be given powers to vet

audit firms in China and Hong Kong. In theory, this could allow New York listed Chinese companies

worth a combined $1.5 trillion to skip delisting. But will China be comfortable with outsiders

digging into their most profitable and strategic companies,

or is it more likely to encourage businesses to seek alternative arrangements? Meanwhile,

it syringes at dawn as producers of two of the world's top COVID-19 vaccine prepare for legal

battle. Moderna reckons Pfizer used some of its intellectual property to make the life-saving remedy.

Given Pfizer estimates the Jabs could generate over $30 billion in sales each year, it's a case worth defending.

And Britain is having a particularly torrid time with inflation.

...